BOIRON And 2 Other Stocks Have Very High Payout Ratio

(VIANEWS) – KBC ANCORA (KBCA.BR), THE NAVIGATOR COMP (NVG.LS), BOIRON (BOI.PA) are the highest payout ratio stocks on this list.

Here’s the data we’ve collected of stocks with a high payout ratio up to now. The payout ratio in itself isn’t a promise of a future good investment but it’s an indicator of whether dividends are being paid and how the company chooses to distribute them.

When investigating a potential investment, the dividend payout ratio is a good statistic to know so here is a list of some companies with an above 30% payout ratio.

1. KBC ANCORA (KBCA.BR)

85.39% Payout Ratio

KBC Ancora SCA holds participating interest in KBC Group SA. The company was formerly known as Almancora SCA and changed its name to KBC Ancora SCA in June 2007. KBC Ancora SCA was incorporated in 1998 and is based in Leuven, Belgium. KBC Ancora SCA is a subsidiary of Cera SC.

Earnings Per Share

As for profitability, KBC ANCORA has a trailing twelve months EPS of €10.3.

PE Ratio

KBC ANCORA has a trailing twelve months price to earnings ratio of 4.11. Meaning, the purchaser of the share is investing €4.11 for every euro of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.98%.

More news about KBC ANCORA.

2. THE NAVIGATOR COMP (NVG.LS)

60.43% Payout Ratio

The Navigator Company, S.A. manufactures and markets pulp and paper products worldwide. The company operates through Market Pulp, UWF Paper, Tissue Paper, and Biomass Renewable Energy segments. It produces bleached eucalyptus kraft pulp, uncoated writing and printing thin paper, and domestic consumption paper under the Navigator, Multioffice, Discovery, explorer, Inacopia, Target, Pioneer, SOPORSET, INASET, and target plus brands for professional and home use. The company also operates cogeneration units and two independent thermoelectric power plants. The company was formerly known as Portucel, S.A. and changed its name to The Navigator Company, S.A. in February 2016. The Navigator Company, S.A. was founded in 1953 and is headquartered in Setúbal, Portugal. The Navigator Company, S.A. is a subsidiary of Semapa – Sociedade de Investimento e Gestão, SGPS, S.A.

Earnings Per Share

As for profitability, THE NAVIGATOR COMP has a trailing twelve months EPS of €0.58.

PE Ratio

THE NAVIGATOR COMP has a trailing twelve months price to earnings ratio of 5.41. Meaning, the purchaser of the share is investing €5.41 for every euro of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 34.26%.

Yearly Top and Bottom Value

THE NAVIGATOR COMP’s stock is valued at €3.14 at 17:10 EST, way under its 52-week high of €4.17 and higher than its 52-week low of €3.05.

Earnings Before Interest, Taxes, Depreciation, and Amortization

THE NAVIGATOR COMP’s EBITDA is 20.83.

More news about THE NAVIGATOR COMP.

3. BOIRON (BOI.PA)

32.87% Payout Ratio

Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary homeopathic medicines and homeopathic specialties; and other healthcare products include medical devices, invitro diagnostics, dietary supplements, cosmetics, and phytotherapy. It also provides homeopathic specialties comprising Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for adjunctive local treatment of benign trauma in the absence of open wounds; Camilia for the treatment of teething problems for babies; Sédatif PC to treat anxiety and emotional, and minor sleep disorders; Coryzalia for the treatment of cold symptoms and rhinitis; Homéoptic to treat eye discomfort and irritation due to various causes for adults and children; Homéovox for vocal disorders; Homéoplasmine for treating irritated skin and redness; Varésol to treat symptoms of chickenpox; and Arnicare Arthritis for use in the treatment of benign trauma pain. In addition, it offers Dermoplasmine, a plant based multi-use balm that repairs and protects irritated and damaged skin; COVID self-tests and rapid antigenic tests; LABIAMEO, that used to treat outbreaks of localized cold sores; and CONVAMEO to treat physical and mental asthenia. The company offers its products through distribution centers, pharmacies, pharmacy chains, wholesalers, grocery and drugstores, health food stores, and online retail. Boiron SA was founded in 1932 and is headquartered in Messimy, France.

Earnings Per Share

As for profitability, BOIRON has a trailing twelve months EPS of €2.89.

PE Ratio

BOIRON has a trailing twelve months price to earnings ratio of 17.47. Meaning, the purchaser of the share is investing €17.47 for every euro of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.13%.

More news about BOIRON.

Leave a Reply

Your email address will not be published. Required fields are marked *